SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 06/21/2024 at 07:00, 2 years 4 months ago

Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran
Sanofi presents new data on ALTUVIIIO and fitusiran at ISTH Congress, showcasing potential first- and best-in-class treatments for hemophilia. Fitusiran NDA under FDA review with PDUFA date of March 28, 2025

Sanofi ALTUVIIIO Fitusiran Hemophilia ISTH Congress
BRIEF

published on 06/12/2024 at 20:24, 2 years 4 months ago

Sanofi: Information on voting rights and shares - May 2024

Voting Rights Investors Actions Sanofi May 2024
PRESS RELEASE

published on 06/12/2024 at 20:19, 2 years 4 months ago

Sanofi: Information concerning the total number of voting rights and shares – May 2024
Sanofi discloses total number of voting rights and shares as per French commercial code and stock market authority regulations. Details available on Sanofi's website

Voting Rights French Commercial Code Shares Sanofi Stock Market Authority
BRIEF

published on 06/03/2024 at 22:20, 2 years 4 months ago

Phase III study: Sarclisa improves progression-free survival of patients with multiple myeloma

Multiple Myeloma Sarclisa ASCO Phase III Study Progression-free Survival
PRESS RELEASE

published on 06/03/2024 at 22:15, 2 years 4 months ago

Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3
Sarclisa in combo with VRd significantly enhances progression-free survival in newly diagnosed transplant-ineligible multiple myeloma in phase 3 study at ASCO. Full data published in NEJM

Multiple Myeloma Phase 3 Sarclisa Progression-free Survival VRd
BRIEF

published on 05/31/2024 at 12:05, 2 years 5 months ago

Sanofi Launches 2024 Global Employee Stock Purchase Plan

Financial Investment Sanofi Employee Stock Purchase Plan Action 2024 Global Participation
PRESS RELEASE

published on 05/31/2024 at 12:00, 2 years 5 months ago

Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
Sanofi launches 2024 global Employee Stock Purchase Plan, Action 2024, offering discounted shares to 80,000 employees in 56 countries. CEO Paul Hudson affirms commitment to employee participation and company growth

Company Growth Sanofi Employee Stock Purchase Plan Action 2024 Employee Shareholders
BRIEF

published on 05/31/2024 at 07:10, 2 years 5 months ago

CHMP recommends approval of Dupixent in the EU for the treatment of patients with COPD

Sanofi COPD Dupixent CHMP Supply
PRESS RELEASE

published on 05/31/2024 at 07:05, 2 years 5 months ago

Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
European Medicines Agency's CHMP recommends Dupixent for EU approval to treat uncontrolled COPD with raised blood eosinophils. If approved, it would be the first targeted therapy for COPD in the EU

Dupixent CHMP EU Approval COPD Treatment Type 2 Inflammation
BRIEF

published on 05/30/2024 at 15:06, 2 years 5 months ago

Sanofi Completes Acquisition of Inhibrx, Inc.

Acquisition Sanofi Rare Diseases Inhibrx SAR447537

Published on 10/30/2026 at 23:35, 2 days 8 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 8 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 2 days 11 hours ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 2 days 12 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 16 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/02/2026 at 07:30, 19 minutes ago

Huawei's 7th Global Installer Summit: Meeting the Best Installers, Building New Home Energy Ecosystem for a Greener Future
Published on 11/02/2026 at 07:30, 20 minutes ago

Mutares portfolio company Efacec is a critical enabler of the global electrification supercycle; order backlog of more than EUR 1.0 billion; strategic exit options under review.
Published on 11/02/2026 at 07:30, 20 minutes ago

Management Board and Supervisory Board of Steyr Motors AG recommend acceptance of Red Cat’s purchase offer
Published on 11/02/2026 at 07:30, 20 minutes ago

FORTEC Elektronik Aktiengesellschaft: Yannick Moyles-Johnson’s appointment as CFO postponed – Acting Chief Financial Officer Henrik Christiansen ensures continuity
Published on 11/02/2026 at 07:05, 44 minutes ago

Lazard Completes Its Acquisition of Campbell Lutyens and Launches Lazard CL, the Global Leader for the Next Era of Private Capital

View all EQS

Published on 10/30/2026 at 23:00, 2 days 8 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days 11 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 13 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 19 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 2 days 23 hours ago

Share buyback

View all LES ECHOS COMFI WIRE

News